Dimensional Fund Advisors
COLL icon

Dimensional Fund Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Dimensional Fund Advisors’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.6M Buy
833,192
+2,712
+0.3% +$115K 0.01% 1817
2025
Q4 		$38.5M Sell
830,480
-611
-0.1% -$25.6K 0.01% 1650
2025
Q3 		$29.1M Sell
831,091
-30,100
-3% -$1.05M 0.01% 1817
2025
Q2 		$25.5M Sell
861,191
-47,815
-5% -$1.36M 0.01% 1853
2025
Q1 		$27.1M Sell
909,006
-66,808
-7% -$2.04M 0.01% 1803
2024
Q4 		$28M Sell
975,814
-72,840
-7% -$2.41M 0.01% 1844
2024
Q3 		$40.5M Buy
1,048,654
+9,630
+0.9% +$343K 0.01% 1636
2024
Q2 		$33.5M Buy
1,039,024
+19,876
+2% +$689K 0.01% 1695
2024
Q1 		$39.6M Sell
1,019,148
-20,070
-2% -$702K 0.01% 1623
2023
Q4 		$32M Buy
1,039,218
+29,529
+3% +$740K 0.01% 1729
2023
Q3 		$22.6M Buy
1,009,689
+27,537
+3% +$628K 0.01% 1860
2023
Q2 		$21.1M Buy
982,152
+25,203
+3% +$572K 0.01% 1900
2023
Q1 		$23M Buy
956,949
+37,546
+4% +$996K 0.01% 1829
2022
Q4 		$21.3K Buy
919,403
+69,089
+8% +$1.39M 0.01% 1839
2022
Q3 		$13.6M Buy
850,314
+30,807
+4% +$543K 0.01% 2025
2022
Q2 		$14.5M Sell
819,507
-29,510
-3% -$496K 0.01% 2032
2022
Q1 		$17.3M Buy
849,017
+50,351
+6% +$951K 0.01% 2036
2021
Q4 		$14.9M Buy
798,666
+42,330
+6% +$825K ﹤0.01% 2145
2021
Q3 		$14.9M Sell
756,336
-19,572
-3% -$423K ﹤0.01% 2143
2021
Q2 		$18.3M Buy
775,908
+193,468
+33% +$4.47M 0.01% 2076
2021
Q1 		$13.8M Sell
582,440
-22,094
-4% -$525K ﹤0.01% 2189
2020
Q4 		$12.1M Buy
604,534
+4,266
+0.7% +$83.3K ﹤0.01% 2207
2020
Q3 		$12.5M Sell
600,268
-5,780
-1% -$104K 0.01% 2088
2020
Q2 		$10.6M Sell
606,048
-26,865
-4% -$526K ﹤0.01% 2181
2020
Q1 		$10.3M Buy
632,913
+20,385
+3% +$421K 0.01% 2103
2019
Q4 		$12.6M Buy
612,528
+29,037
+5% +$484K ﹤0.01% 2264
2019
Q3 		$6.7M Buy
583,491
+25,873
+5% +$295K ﹤0.01% 2497
2019
Q2 		$7.33M Buy
557,618
+129,532
+30% +$1.73M ﹤0.01% 2507
2019
Q1 		$6.48M Buy
428,086
+255,619
+148% +$4.09M ﹤0.01% 2565
2018
Q4 		$2.96M Buy
172,467
+156,614
+988% +$2.68M ﹤0.01% 2748
2018
Q3 		$234K Hold
15,853
– – ﹤0.01% 3290
2018
Q2 		$378K Hold
15,853
– – ﹤0.01% 3165
2018
Q1 		$405K Hold
15,853
– – ﹤0.01% 3135
2017
Q4 		$293K Hold
15,853
– – ﹤0.01% 3166
2017
Q3 		$166K Hold
15,853
– – ﹤0.01% 3240
2017
Q2 		$198K Buy
+15,853
New +$157K ﹤0.01% 3199

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Dimensional Fund Advisors's COLL Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Collegium Pharmaceutical (COLL) stake by 0.33% in Q1 2026, buying an estimated $115K and bringing the position to 833,192 shares worth $27.6M. The position accounts for 0.01% of the portfolio, ranked #1817.

Dimensional Fund Advisors first reported a position in COLL in Q2 2017 and has held it in 36 quarters since. The position peaked at $40.5M in Q3 2024. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Dimensional Fund Advisors held 833,192 shares of Collegium Pharmaceutical worth $27.6M as of Q1 2026.
  • Dimensional Fund Advisors bought 2,712 Collegium Pharmaceutical shares in Q1 2026, an estimated $115K.
  • Collegium Pharmaceutical made up 0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #1817 holding.
  • Dimensional Fund Advisors first reported a position in Collegium Pharmaceutical in Q2 2017 and has held it in 36 quarters since.
  • Dimensional Fund Advisors's Collegium Pharmaceutical position peaked at $40.5M in Q3 2024.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.